Clinical Trials Logo

Filter by:
NCT ID: NCT06262334 Recruiting - Clinical trials for Health Related Quality of Life

Evaluating the Fade to Fitness Program: A Barbershop-based Program for Black Men

Start date: March 20, 2024
Phase: N/A
Study type: Interventional

The Fade to Fitness Program is a targeted intervention designed to improve the holistic health and quality of life among Black men. This comprehensive initiative focuses on four key health behaviors: Physical Activity, Healthy Eating, Stress Management, and Depression Management. It is grounded in psychological and social theories like Self-Determination Theory, Motivational Interviewing, and Social Cognitive Theory. The program emphasizes the importance of making informed choices, feeling competent and connected, and learning through observation and modeling. Facilitators play a pivotal role, leading group discussions, providing support, and fostering an inclusive atmosphere. The program is structured into weekly sessions that tackle each health behavior, interspersed with off weeks; for community engagement, especially in barbershops, to discuss health topics and promote a healthier lifestyle.

NCT ID: NCT06262321 Recruiting - Radiotherapy Clinical Trials

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

DRO2301
Start date: May 15, 2024
Phase: Phase 2
Study type: Interventional

Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standard of care systemic therapy.

NCT ID: NCT06262126 Recruiting - Chest Pain Clinical Trials

Virtual Reality for Non-cardiac Chest Pain

Start date: February 14, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).

NCT ID: NCT06261957 Recruiting - Asthma Clinical Trials

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma

Start date: May 31, 2024
Phase: Phase 3
Study type: Interventional

The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged 12 years and above with asthma.

NCT ID: NCT06261905 Recruiting - Opioid Use Disorder Clinical Trials

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Start date: March 13, 2024
Phase: Phase 1
Study type: Interventional

The research team is investigating Opioid Use Disorder (OUD), a disorder characterized by dysregulated dopaminergic tone, to evaluate the mechanisms of adjunctive treatment with calcitriol. The investigators will recruit 12 subjects with OUD and 12 healthy subjects to participate in a double-blind, randomized study design where subjects will complete up to 2 Positron Emission Tomography (PET) scans using [11C]-PHNO. The investigators will compare subjects in differences between their own study days and in differences between healthy control subjects and subjects with OUD.

NCT ID: NCT06261736 Recruiting - Clinical trials for Stress Urinary Incontinence

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

Start date: October 24, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

NCT ID: NCT06261619 Recruiting - Airway Management Clinical Trials

Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Effective respiratory ventilation is achieved by moving the right amount of air to and out of the lungs while keeping the pressures at a safe level. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery. In this superiority study, the investigators will perform two-group cross over randomized design to test the superiority of the Adult Sotair® device compared to manual ventilation alone.

NCT ID: NCT06261528 Recruiting - Clinical trials for Progressive Multiple Sclerosis

Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis

NO-FATIGUE
Start date: April 18, 2024
Phase: Phase 1
Study type: Interventional

The study is being done to determine if treatment with a novel form of light therapy is tolerated in patients with progressive multiple sclerosis. The goal of this trial to establish the safety profile of this light therapy while generating data on its impact on fatigue, as well as its mechanism of action. Fatigue is often a complex symptom in multiple sclerosis, without any FDA-approved direct therapy. Fatigue is traditionally treated with symptom management through a multidisciplinary team.

NCT ID: NCT06261476 Recruiting - Healthy Clinical Trials

Safety of Ashwagandha (Withania Somnifera) Root Extract

Start date: February 2024
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the laboratory safety of Ashwagandha standardized root extract 500 mg capsules in healthy adults over 12-week therapy based on Complete Blood Count, Renal Function Test, Liver Function Test, Lipid Profile and Thyroid Function Test, Fasting blood sugar and HbA1c Test. The secondary objectives are to evaluate the clinical safety of Ashwagandha standardized root extract 500 mg capsules in healthy adults over 12-week therapy and to evaluate the effect of the Ashwagandha standardized root extract 500 mg on Quality of Life (QoL) using the SF-36 tool.

NCT ID: NCT06261463 Recruiting - Depression Clinical Trials

Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

The proposed study draws on prior research to evaluate the feasibility, acceptability and explore preliminary effectiveness of Coffee and Family Education and Support, Version (CAFES2) using a pilot randomized type 1 hybrid effectiveness-implementation design. CAFES2 is a peer-led family and social strengthening multiple family group intervention that is designed to respond to multi-level needs of refugee families. Results of the trial will contribute to the emerging evidence base on family-based mental health interventions for refugee and newcomer communities. The trial will also generate new insights regarding implementation strategies needed to promote successful delivery of services by peer providers and the unique role of human-centered design practices for adaptation of mental health and psychosocial interventions.